Apoe epsilon4 allele frequency in patients with dementia in different ethnic and geographic groups;Farklı etnik ve coǧrafik gruplardaki demanslı hastalarda apoe epsilon4 allel sıklıǧı

Turkish Journal of Biochemistry

Volumn 35, Issue 3, 2010, Pages 163-171

  Aslan, Diler ^a   Ercan, Funda ^a   Aybek, Hülya ^a   Şahiner, Türker ^b  

^a Departments of Biochemistry   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Alzhiemer; Apoe4; Disease; Polymorphism; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; ASIA; CONTROLLED STUDY; ETHNICITY; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; POPULATION GENETICS; PROTEIN POLYMORPHISM; WESTERN HEMISPHERE;

EID: 78449243618     PISSN: None     EISSN: 1303829X     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, Albert M, Blacker D, Stern Y. (2008) APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology. 70:1842-1849.
2. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 278(16): 1349-1356.
3. Kim KW, Youn JC, Han MK, Paik NJ, Lee TJ, Park JH, Lee SB, Choo IH, Lee DY, Jhoo JH, Woo JI. (2008) Lack of association between apolipoprotein E polymorphism and vascular dementia in Koreans. J Geriatr Psychiatry Neurol. 21(1):12-17
4. Villalpando-Berumen JM, Mejia-Arango S, Ordonez-Sanchez ML, Gutierrez-Robledo LM. (2008) Apolipoprotein E e4, Alzheimer's Disease, and Cognitive Performance in Elderly Mexican Mestizos. J Am Geriatr Soc 56:677-682.
5. Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Stop-ford C, Julien C, Thompson J, Payton A, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DMA, (2007) Apolipoprotein E _ 4 Allele Frequency and Age at Onset of Alzheimer's Disease. Dement Geriatr Cogn Disord. 23:60-66.
6. Baum L, Lam LCW, Kwok T, Lee J, Chiu HFK, Mok VCT, Wong A, Chen X, Cheung WS, Pang CP, Ma SK, Tang NLS, Wong KS, Keung H. (2006) Apolipoprotein E £4 Allele Is Associated with Vascular Dementia Dement Geriatr Cogn Disord. 22:301-305.
7. Mahley RW, Weisgraber KH, Huang Y. (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A. 103(15):5644-5651.
8. Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T. (2005) Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neuro-sci Lett. 25;375(1):1-6.
9. Yokeş MB, Emre M, Harmanci H, Gürvit H, Hanaǧasi H, Şahin H, Bilgiç B, Başak AN. (2005) The apolipoprotein E (APOE) genotype in a Turkish population with Alzheimer'd Disease. Balkan J. Med Genet. 8:57-63.
10. Huang W, Qiu C, Strauss EV, Winblad B, Fratiglioni L. (2004) APOE Genotype, Family History of Dementia, and Alzheimer Disease Risk. Arch Neurol. 61: 1930-1934.
11. Scarmeas N, Anderson KE, Hilton J, Park A, Habeck C, Flynn J, Tycko B, Stern Y. (2004) APOE-dependent PET patterns of brain activation in Alzheimer disease. Neurology. 63(5):913-915.
12. Bang OY, Kwak YT, Joo IS, Huh K. (2003) Important link between dementia subtype and apolipoprotein E: a meta-analysis. Yonsei Med J. 44(3):401-413.
13. Blazer DG, Fillenbaum GG, Gold DT, Burchett BM, Hays JC. (2003) APOE epsilon4 as a predictor of subjective quality of life in a biracial older person community sample. J Aging Health. 15(4):645-660.
14. Engelborghs S, Dermaut B, Goeman J, Saerens J, Mariën P, Pic-kut BA, Van den Broeck M, Serneels S, Cruts M, Van Broeck-hoven C, De Deyn PP. (2003) Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry. 74(8):1148-1151.
15. Mayeux R, Small SA, Tang M, Tycko B, Stern Y. (2001) Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiol Aging. 22(4):683-689.
16. Siest G, Bertrand P, Qin B, Herbeth B, Serot JM, Masana L, Rib-alta J, Passmore AP, Evans A, Ferrari M, Franceschi M, Shepherd J, Cuchel M, Beisiegel U, Zuchowsky K, Rukavina AS, Sertic J, Stojanov M, Kostic V, Mitrevski A, Petrova V, Sass C, Merched A, Salonen JT, Tiret L, Visvikis S. (2000) Apolipopro-tein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. Apo Europe group. Clin Chem Lab Med. 38(8):721-730.
17. Polvikoski T, Sulkava A, Haltia A, Kainulainen A, Vuorio A, Verkkoniemi U, Niinistö E, Halonen I, Kontula K. (1995) Apoli-poprotein E, Dementia, and Cortical deposisition of b. N Engl J Med. 333:1242-1247.
18. Cherbuin N, Leach LS, Christensen H, Anstey KJ. Neuroimag-ing and APOE genotype: a systematic qualitative review. De-ment Geriatr Cogn Disord. 2007;24(5):348-362.
19. Engelborghs S, Dermaut B, Mariën P, Symons A, Vloeberghs E, Maertens K, Somers N, Goeman J, Rademakers R, Van den Broeck M, Pickut B, Cruts M, Van Broeckhoven C, De Deyn PP. (2006) Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiol Aging. 27(2):285-292.
20. Gdovinová Z, Habalová V, Novosadová Z. (2006) Polymorphism of Apolipoproteine E in Relation with Alzheimer and Vascular Dementia Cellular and Molecular Neurobiology 26:1219-1224.
21. Sabbagh M. (2008) Commentary "The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics". Alzheimer and Dementia. 4(3);174-175.
22. Bird TD. (2007) Alzheimer Disease Overview. 1-22 Accessed: December 2009, http://www.geneclinics.org/profiles/alzheimer/details.html.
23. Cedazo-Mínguez A. (2007) Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. J. Cell. Mol. Med. 11(6):1227-1238.
24. Sadowski MJ, Pankiewicz J, Scholtzova H, Mehta PD, Prelli F, David D, and Wisniewski T. (2006) Blocking the apolipopro-tein E/amyloid- interaction as a potential therapeutic approach for Alzheimer's disease. PNAS. 103:18787-18792 www.pnas.org_cgi_doi_10.1073_pnas.0604011103.
25. Sparks DL, Connor DJ, Sabbagh MN, Petersen RB, Lopez J, Browne P. (2006) Circulating cholesterol levels, apolipopro-tein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial. Acta Neurol Scand. 114 (Suppl. 185): 3-7.
26. Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, Hachinski V, Cedazo-Minguez A, Soininen H, Tu-omilehto J, Nissinen A. (2008) Apolipoprotein E ε4 Magnifies Lifestyle Risks for Dementia: A Population Based Study. J Cell Mol Med. 12(6B):2762-2771.
27. Gürvit H, Emra M, Tinaz S, Bilgic B, Hanagasi H, Sahin H, Gu-rola E, Kvaloy JT, Harmanci H. (2008) The prevalence of dementia in an urban Turkish Population. AJADD. 23(1):67-76.
28. Serretti A, Olgiati P, De Ronchi D. (2007) Genetics of Alzheimer's disease. A rapidly evolving field. JAD. 12 (1):73-92.
29. Harmanci, H, Emre M, Gurvit H, Bilgic B, Hanagasi H, Gurol E, Sahin H, Tinaz S, (2003) Risk Factors for Alzheimer Disease: A Population-Based Case-Control Study in Istanbul, Turkey. Alzheimer Dis Assoc Disord. 17:139-145.
30. Morris JC, Heyman A, Mohs RC, Hughes JP, Van Bell G, Fillen-baum G, Mellits ED, Clark C. (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 39:1159-1165.
31. Güngen C, Ertan T, Eker E, Yaşar R, Engin F. (2002) Standardize Mini Mental Test'in Türk Toplumunda Hafif Demans Tani{dotless}si{dotless}nda Geçerlik ve Güvenilirliǧi. Türk Psikiyatri Derg. 13:273-281.
32. Rosen WG, Mohs RC, Davis KL. (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry. 141:1356-1364.
33. Aybek H, Ercan F, Aslan D, Şahiner T. (2007) Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. Clinical Biochemistry. 40:172-176.
34. Brichtová E, Kozák L. (2008) Apolipoprotein E genotype and traumatic brain injury in children-association with neurological outcome. Childs Nerv Sys.t 24:349-356.
35. Sazci A, Akpinar G, Aygun C, Ergul E, Senturk O, Hulagu S. (2008) Apolipoprotein E polymorphisms in patients with nonalcoholic steatohepatitis. Dig Dis Sci. 53(12):3218-3224.
36. Onat A, Hergenç G, Ayhan K, Kaya Z, Küçükdurmaz Z, Bulur G, Can G, Ünaltuna NE. (2007) Serum apolipoprotein E concentrations among Turks: information additive to genotype relative to dyslipidemia and metabolic seydrom. Türk Kardiyol Dern. Araş. 35:449-457.
37. Mendes-Lana A, Pena G.G, Freitas S.N, Lima A.A, Nicolato R.L.C, Nascimento-Neto R.M, Machado-Coelho G.L.L, Freitas R.N. (2007) Apolipoprotein E polymorphism in Brazilian dys-lipidemic individuals: Ouro Preto study. Braz J Med Biol Res. 40(1):49-56
38. Thakkinstian A, Bowe S, McEvoy M, Smith W, Attia J. (2006) Assosiation between apolipoprotein E polymorphism and age-related macular degeneration: a Huge review and Meta-Analysis. Am J Epidomiol. 164(9): 813-822.
39. Singh PP, Singh M, Mastana SS. (2006) APOE distribution in world populations with new data from India and the UK. Annals of Human Biology. 33(3): 279-308.
40. Attila G, Acartürk E, Eskandari G, Akpiinar O, Tuli T, Kanadaşi M, Kayrin L. (2001) Effects of apoli. Clin Chim Acta. 312(1-2):191-196.
41. Al-Khedhairy AA. (2005). Apolipoprotein E polymorphism in Saudis. Molecular Biology Reports. 31(4):257-260.
42. Baird PN, Guida E, Chu DT, Vu HTV, Guymer RH. (2004) The 2 and 4 Alleles of the Apolipoprotein Gene Are Associated with Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 45:1311-1315.
43. Duman BS, Oztürk M, Yilmazer S, Hatemi H. (2004) Apolipo-protein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations. Diabetes Nutr Metab. 17(5):267-274.
44. Duzenli S, Pirim I, Gepdiremen A, Deniz O. (2004) Apolipro-tein E polymorphism ans stroke in population from Eastern Turkey. Journal of Neurogenetics, 18:1, 365-375.
45. Thelma, B. K. (2001) "APOE Polymorphism in a Rural Older Population-Based Sample in India" Hum Biol. 73(1):135-144.
46. Isbir T, H Yilmaz, B Agachan, ZE Karaali. (2003) Cholesterol ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population. Clin Genet. 64:228-234.
47. Brega A, Scacchi R, Cuccia M, Kirdar B, Peloso G, Corbo RM. (1998) Study of 15 protein polymorphisms in a sample of the Turkish population. Hum Biol. 70(4):715-728.
48. Sklavounou E, Economou-Petersen E, Karadima G, Panas M, Avramopoulos D, Varsou A, Vassilopoulos D, Petersen MB. (1997) Apolipoprotein E polymorphism in the Greek population. Clin Genet. 52: 216-218.
49. Mahley RW, Palaoǧlu KE, Atak Z, Dawson-Pepin J, Lan-glois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F, Özbayrakçi S, Gökdemir O, Winkler W. (1995) Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res. 36(4):839-859.
50. Ribalta J, Halkes CJM, Salazar J, Masana L, Cabezas MC. (2005) Additive Effects of the PPAR7, APOE, and FABP-2 Genes in Increasing Daylong Triglycerides of Normolipidemic Women to Concentrations Comparable to Those in Men Clin. Chem. 51: 864 - 871.
51. Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, MacAvoy M, Gelernter J, van Dyck C. (2006) Apolipoprotein E 4 Allele Is Unrelated to Cognitive or Functional Decline in Alzheimer's Disease: Retrospective and Prospective Analysis-Dement Geriatr Cogn Disord. 22:73-82.